Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol-Reference-Cited by-同舟云学术

Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol

Published:2015-05-06 Issue:6 Volume:4 Page:407-417
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Hsiao Hsiu-ling¹,Langenickel Thomas Heiko²,Greeley Michael³,Roberts John³,Zhou Wei¹,Pal Parasar⁴,Rebello Sam¹,Rajman Iris²,Sunkara Gangadhar¹

Affiliation:

1. Novartis Institutes for Biomedical Research; Novartis Pharmaceuticals Corporation; East Hanover NJ USA

2. Novartis Pharma AG; Basel Switzerland

3. Oncology Clinical Pharmacology; Novartis Pharmaceuticals Corporation; East Hanover NJ USA

4. Novartis Healthcare Pvt. Ltd.; Hyderabad; India

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference33 articles.

1. Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi);Gu;J Clin Pharmacol,2010

2. Natriuretic peptide system: an overview of studies using genetically engineered animal models;Kishimoto;FEBS J,2011

3. Thirty years of research on atrial natriuretic factor: historical background and emerging concepts;de Bold;Can J Physiol Pharmacol,2011

4. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications;Potter;Handb Exp Pharmacol,2009

5. Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases;Kuhn;Handb Exp Pharmacol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study;RSC Advances;2024

2. Synchronized determination of sacubitril and valsartan with some co‐administered drugs in human plasma via UPLC–MS/MS method using solid‐phase extraction;Biomedical Chromatography;2021-06-29

3. Synchronized determination of the novel heart failure combination therapy containing sacubitril calcium and valsartan by a validated spectrofluorimetric method;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-05

4. Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence;Hypertension;2021-01

5. Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?;Current Cardiology Reviews;2020-01-28